APA citiranje

Kojima, Y., Downing, K., Kundu, R., Miller, C., Dewey, F., Lancero, H., . . . Leeper, N. J. (2019). Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest.

Citação norma Chicago

Kojima, Yoko, et al. "Cyclin-dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis." J Clin Invest 2019.

MLA citiranje

Kojima, Yoko, et al. "Cyclin-dependent Kinase Inhibitor 2B Regulates Efferocytosis and Atherosclerosis." J Clin Invest 2019.